These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 21654328)

  • 1. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
    Purushothaman S; Sathik MM; Nair RR
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Modulation by Medium-Chain Triglycerides Reduces Oxidative Stress and Ameliorates CD36-Mediated Cardiac Remodeling in Spontaneously Hypertensive Rat in the Initial and Established Stages of Hypertrophy.
    Saifudeen I; Subhadra L; Konnottil R; Nair RR
    J Card Fail; 2017 Mar; 23(3):240-251. PubMed ID: 27530817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.
    Ismael S; Purushothaman S; Harikrishnan VS; Nair RR
    Mol Cell Biochem; 2015 Aug; 406(1-2):173-82. PubMed ID: 25976666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.
    Huang J; Xu L; Huang Q; Luo J; Liu P; Chen S; Yuan X; Lu Y; Wang P; Zhou S
    J Cell Mol Med; 2015 Jul; 19(7):1672-88. PubMed ID: 25753319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
    Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
    J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
    Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.
    Ismael S; Nair RR
    Mol Cell Biochem; 2021 Jan; 476(1):483-491. PubMed ID: 33000353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats].
    Chen HJ; Chen JZ; Wang XX; Yu M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):470-6. PubMed ID: 17924466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
    Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.
    Castiglioni L; Pignieri A; Fiaschè M; Giudici M; Crestani M; Mitro N; Abbate M; Zoja C; Rottoli D; Foray C; Fiordaliso F; Guerrini U; Tremoli E; Sironi L; Gelosa P
    J Hypertens; 2018 May; 36(5):1129-1146. PubMed ID: 29278547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.
    Li CB; Li XX; Chen YG; Zhang C; Zhang MX; Zhao XQ; Hao MX; Hou XY; Gong ML; Zhao YX; Bu PL; Zhang Y
    J Cell Mol Med; 2009; 13(11-12):4444-52. PubMed ID: 18754816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
    Dhahri W; Couet J; Roussel É; Drolet MC; Arsenault M
    Life Sci; 2013 Jan; 92(1):26-34. PubMed ID: 23142240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.
    Li P; Luo S; Pan C; Cheng X
    Mol Med Rep; 2015 Dec; 12(6):7899-906. PubMed ID: 26497978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
    Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
    Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
    Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat.
    Tang Y; Mi C; Liu J; Gao F; Long J
    Cardiovasc Pathol; 2014; 23(2):101-6. PubMed ID: 24388463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A; Seymour AM
    Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.